NSCLC	non-small cell lung cancer
TKI	tyrosine kinase inhibitor
MET	mesenchymal-epithelial transition
TME	tumor microenvironment
EMT	epithelial-mesenchymal transition
CAF	cancer-associated fibroblast
TAM	tumor-associated macrophage
PFS	progression-free survival
EOMES	eomesodermin
TCGA	The Cancer Genome Atlas
OS	overall survival
ORR	overall response rate
DCR	disease control rate
IRAE	immune-related adverse event